Experimental findings have proposed that PD-L1 bound to the surface of exosomes can effectively interact with PD-1 receptors, resulting in inhibition of T cell activation, suppression of apoptosis in breast cancer cells, and facilitation of tumor immune evasion (61). Here, CD274 is linked to breast carcinoma.